A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF

Development

Volumn 125, Issue 9, 1998, Pages 1591-1598

  Benjamin, Laura E ^a   Hemo, Itzhak ^b   Keshet, Eli ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Blood vessel; PDGFB; Pericyte; Rat; Vascular system; VEGF

Indexed keywords

ALPHA ACTIN; OXYGEN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; NEWBORN; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0031834239     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J. and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028.
2. Beck, L., Jr. and D'Amore, P. A. (1997). Vascular development: cellular and molecular regulation. FASEB 11, 365-373.
3. Benjamin, L. E. and Keshet, E. (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94, 8761-8766.
4. Brooks, P. C., Clark, R. A. and Cheresh, D. A. (1994a). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571.
5. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A. (1994b). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
6. Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, I., Demunck, H., Kasper, M., Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T. and Collen, D. (1996). Role of tissue factor in embryonic blood vessel development. Nature 383, 73-75.
7. Diaz Flores, L., Gutierrez, R., Varela, H., Rancel, N. and Valladares, F. (1991). Microvascular pericytes: a review of their morphological and functional characteristics. Histol. Histopathol. 6, 269-286.
8. Drake, C. J. and Little, C. D. (1995). Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA 92, 7657-7661.
9. Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A. and Breitman, M. L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897- 1909.
10. Folkman, J. and D'Amore, P. A. (1996). Blood vessel formation: what is its molecular basis. Cell 87, 1153-1155.
11. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A. and Cheresh, D. A. (1995). Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500-1502.
12. Friedlander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S. and Cheresh, D. A. (1996). Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. USA 93, 9764-9769.
13. Gibson, D. L., Sheps, S. B., Uh, S. H., Schechter, M. T. and McCormick, A. Q. (1990). Retinopathy of prematurity-induced blindness: Birth weight- specific survival and the new epidemic. Pediatrics 86, 405-412.
14. Leveen, P., Pekny, M., Gebre Medhin, S., Swolin, B., Larsson, E. and Betsholtz, C. (1994). Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887.
15. Lindahl, P., Johansson, B. R., P., L. and Betsholtz, C. (1997). Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice. Science 277, 242-245.
16. Meredith, J. E. and Schwartz, M. A. (1997). Integrins, adhesion and apoptosis. Trends Cell Biol. 1, 146-150.
17. Mudhar, H.S., Pollock, R.A., Wang, C., Stiles, C.D. and Richardson, W.D. (1993). PDGF and its receptors in the developing rodent retina and optic nerve. Development 118, 539-552.
18. Nehls, V., Denzer, K. and Drenckhahn, D. (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 270, 469- 474.
19. Nicosia, R. F. and Villaschi, S. (1995). Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab. Invest. 73, 658-666.
20. Nomura, M., Yamagishi, S., Harada, S., Hayashi, Y., Yamashima, T., Yamashita, J. and Yamamoto, H. (1995). Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270, 28316-28324.
21. Orlidge, A. and D'Amore, P. A. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455-1462.
22. Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R. (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902-906.
23. Puri, M. C., Rossant, J., Alitalo, K., Bernstein, A. and Partanen, J. (1995). The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14, 5884-5891.
24. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 631-742.
25. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg Buchholz, K., Fujiwara, Y., Gendron Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
26. Sato, Y. and Rifkin, D. B. (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109, 309-315.
27. Shweiki, D., Itin, A., Soffer, D., Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
28. Speiser, P., Gittelsohn, A. M. and Patz, A. (1968). Studies on diabetic retinopathy. III. Influence of diabetes on intramural pericytes. Arch. Ophtlalmol. 80, 332-337.
29. Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan Ling, T. and Keshet, E. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747.
30. Stone, J. and Maslim, J. (1997). Mechanisms of retinal angiogenesis. Progress in Retinal and Eye Research 16, 157-181.
31. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis [see comments]. Cell 87, 1171-1180.
32. Takagi, H., King, G. L. and Aiello, L. P. (1996). Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes 45, 1016-1023
33. Vikkula, M., Boon, L. M., Carraway, K. L. r., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., Mulliken, J. B. and Olsen, B. R. (1996). Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kmase TIE2 [see comments]. Cell 87, 1181-1190.